Related Experiment Video
Updated: Jun 19, 2026

Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches
Published on: October 27, 2013
Infections due to Phialemonium species: case report and review
María Rivero1, Angel Hidalgo, Ana Alastruey-Izquierdo
1Sección de Medicina Interna, Clínica Ubarmin, Elcano, Navarra, Spain.
Abstract:
Abstract Infections caused by rarely encountered fungal pathogens have increased in recent decades. The present study describes a disseminated infection caused by Phialemonium curvatum, and reviews the literature in an effort to summarize prior experiences with this unusual pathogen. The clinical and microbiological characteristics of a new case due to Phialemonium are presented. The case is analysed with 19 other which have appeared in the literature since 1986. Ten cases were sporadic infections, while the others were associated with three small outbreaks. In all but our patient the skin's natural barrier was compromised (15/20 [75%]) and immunosuppression was a factor in the majority of cases (14/20 [70%]). Dissemination was noted in 83% (5/6) of the immunocompetent patients and in 57% (8/14) of immunocompromised patients. Endocarditis was the most frequent form of infection (8/20 [40%]). Blood cultures were positive in 92% (12/13) of those with disseminated disease. The mortality rate was 54% (7/13) among those with disseminated infections, but fatal outcomes were not observed in patients receiving treatment with itraconazole, voriconazole or posaconazole. The in vitro susceptibility of Phialemonium indicated a more consistent level of activity for voriconazole and posaconazole. Although infections usually occur when there is a breakdown in the skin the skin barrier or host defences are weakened, our case points out that infections due to Phialemonium species may occur in patients without these risk factors. The most frequent form of Phialemonium infections is endovascular, often with endocarditis and positive blood cultures, associated with high mortality rates. Treatment with the new triazoles is associated with improved survival.
Insights
Rare fungal infections are increasing. Phialemonium curvatum can cause disseminated disease, often endocarditis, with high mortality. New triazole antifungals like voriconazole show promise for treating Phialemonium infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
Background:
- Infections by rare fungal pathogens, such as Phialemonium curvatum, are increasingly reported.
- This study details a disseminated Phialemonium curvatum infection and reviews existing literature.
Observation:
- A review of 20 cases (1 new, 19 literature) of Phialemonium infections revealed compromised skin barriers (75%) and immunosuppression (70%) as common factors.
- Dissemination occurred in 83% of immunocompetent and 57% of immunocompromised patients.
- Endocarditis was the most frequent presentation (40%), with positive blood cultures in 92% of disseminated cases.
Findings:
- Disseminated Phialemonium infections have a high mortality rate (54%).
- No fatal outcomes were observed in patients treated with newer triazoles (itraconazole, voriconazole, posaconazole).
- In vitro studies showed consistent activity of voriconazole and posaconazole against Phialemonium.
Implications:
- Phialemonium infections, primarily endovascular, pose a significant threat, especially endocarditis.
- Newer triazole antifungals are associated with improved survival rates.
- This pathogen can cause infections even in individuals without typical risk factors like compromised skin barriers or weakened host defenses.
Related Concept Videos
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Fungal Phylum Microsporidia